Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Addictions
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Addictions
    Buprenorphine Effective in Treatment of Heroin Dependency - (DGNews)
    TopAbstracts in Addictions 06/26/2008 - (DGNews)
    TopAbstracts in Addictions 06/12/2008 - (DGNews)
    Topiramate Reduces Heavy Drinking and Symptoms of Alcoholism - (DGNews)
    Clusters of Genetic Variants Linked to Distinct Treatment Responses for Smoking Cessation - (DGNews)

    News archive

     Recent webcasts/CME - Addictions
      Balanced Opioid Prescribing
      Opioid Addiction: No Reason to Withhold Pain Management
      Drugs of Abuse: A Pharmacist's Guide
      Achieving Treatment Success in Alcohol Dependence: Integrating Pharmacologic and Psychosocial Approaches
      ADHD and Co-Occurring Substance Use Disorders: New Clinical Insights and Emerging Therapies

      Webcasts/CME archive

       Recent cases - Addictions
        Decrease in Tobacco Consumption After Treatment with Topiramate and Aripiprazole
        Calcific Myofibrosis Due to Pentazocine Abuse: A Case Report
        A Novel SPINK1 Gene Mutation, c.206C>T, in a Thai Patient with Chronic Alcoholic Pancreatitis
        Community-Acquired Klebsiella Pneumoniae Meningitis in an Alcoholic Patient with an Infected Pancreatic Pseudocyst: A Case Report and Review of the Literature
        Coal Tar Creosote Abuse by Vapour Inhalation Presenting with Renal Impairment and Neurotoxicity: A Case Report

        Cases archive
          




        my personal edition > addictions > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Alcoholics Do Well On Naltrexone Along With Skills Training

        Alcoholism: Clinical and Experimental Research

        11/15/2001
        By Anne MacLennan


        Alcoholics should be kept on naltrexone treatment for longer periods of time and also be encouraged to increase their compliance with it.

        The drug clearly works, helping to reduce or even to prevent relapse in those who continue to take it, although it is probably underused, suggests this study.

        Valuable adjuncts to this treatment are both coping- and communication-skills training, which help patients once they have begun recovery to maintain treatment gains.

        Peter M. Monti and colleagues from the Providence VA Medical Center; Center for Alcohol and Addiction Studies, Brown University; Butler Hospital/Brown University; and Butler Hospital/Brown University School of Medicine, all in Providence, Rhode Island, United States, did this study.

        Objective was to investigate the effects of combining naltrexone (NTX), cue exposure combined with urge-specific coping skills training (CET) and communication skills training (CST) as treatment adjuncts.

        In a two-by-two design, researchers examined the effects of CET plus CST versus an education and relation control treatment over a two-week partial hospital program (165 patients) followed by 12 weeks of NTX (50 mg/day) or placebo during aftercare (128).

        Patients were medically eligible alcohol dependents.

        Drinking outcomes were assessed at three, six and 12 months after partial hospital discharge. Process measures included urge, self-efficacy (confidence about staying abstinent in risky situations) and self-reported coping skills.

        Alcoholics who took the naltrexone for at least 70 percent of days, or two of the three months it was prescribed, had fewer heavy drinking days, fewer drinks if they did drink and fewer urges to drink.

        However, naltrexone's beneficial effects lasted only while patients took it, suggesting outcomes would improve if the drug were prescribed for more than 90 days and compliance remained high.

        Patients who received the coping- and communication-skills training versus control patients were significantly less likely to report a relapse day and reported fewer heavy drinking days at the six- and 12-month follow-ups.

        Process measures showed NTX resulted in lower weekly urge ratings, and those in skills training used more of the prescribed coping skills after treatment and reported fewer cue-elicited urges and more self-efficacy.

        Drinking reductions at three, six and 12 months correlated with more use of coping skills, lower urge and higher self-efficacy.
        Alcoholism: Clinical and Experimental Research 2001;25:1634-1647.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send